| 000 | 01596 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515011104.0 | ||
| 264 | 0 | _c20070906 | |
| 008 | 200709s 0 0 chi d | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFan, Yun | |
| 245 | 0 | 0 |
_a[MINE regimen for patients with relapsed or chemo-resistant invasive non-Hodgkin's lymphoma]. _h[electronic resource] |
| 260 |
_bAi zheng = Aizheng = Chinese journal of cancer _cDec 2005 |
||
| 300 |
_a1503-6 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIfosfamide _xadministration & dosage |
| 650 | 0 | 4 |
_aLeukopenia _xchemically induced |
| 650 | 0 | 4 |
_aLymphoma, B-Cell _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma, T-Cell _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMitoguazone _xadministration & dosage |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
| 650 | 0 | 4 |
_aVinblastine _xadministration & dosage |
| 700 | 1 | _aHuang, Zhi-Yu | |
| 700 | 1 | _aLuo, Lu-Hong | |
| 700 | 1 | _aYu, Hai-Feng | |
| 773 | 0 |
_tAi zheng = Aizheng = Chinese journal of cancer _gvol. 24 _gno. 12 _gp. 1503-6 |
|
| 999 |
_c15972309 _d15972309 |
||